The Operational Vital Signs
Key metrics on the metabolic health of military.
69%
Active Duty Overweight
69% of active duty service members are currently classified as overweight or obese — despite mandatory fitness standards.
24.2%
Clinically Obese (2025)
Clinical obesity rates have risen from 14.7% in 2013 to 24.2% in 2025 — a 65% increase in 12 years.
25–40%
Injury Risk Increase
Excess weight increases musculoskeletal injury risk by 25–40% during high-load training and operational activity.
74%
VA GLP-1 Success Rate
74% of VA patients on GLP-1 therapy lost 5% or more of body weight at 12 months. Average loss: 10%.
The Threat Matrix
The Readiness Gap
The Reality: Excess weight and metabolic disease are increasingly affecting deployability, unit performance, and career longevity.
The Impact: Weight is now the leading reason civilian recruits fail military entry and a significant driver of early medical separation from service.
The Reality: VA real-world data confirms GLP-1 effectiveness: 74% of patients lost ≥5% body weight at 12 months.
The Impact: Associated improvements include 3.4 mmHg blood pressure reduction and 0.32% A1c reduction — meaningful clinical outcomes.
The Injury Cycle
The Reality: Carrying excess weight during high-load training increases musculoskeletal injury risk by 25–40%.
The Impact: Injuries create activity restrictions, which worsen metabolic health, which increase reinjury risk — a documented military health cycle.
The Reality: GLP-1 therapy reduces systemic inflammation contributing directly to joint degeneration and impaired recovery.
The Impact: Weight reduction decreases mechanical load on joints during training, lowering baseline injury risk before a training cycle begins.
Comorbidity Management Add-On
Included
- Lab work and bloodwork evaluation
- Hypertension management & prescriptions
- Prediabetes & blood sugar management
- High cholesterol management
- Ongoing medication adjustments
Not Included
- Acute, urgent, or sick care visits
- Emergency care
- Specialist referrals
- Concierge services
Veterans and active duty managing multiple metabolic conditions may benefit from consolidated clinical oversight.
Add-On: $65/month
Available to any active patient
Pricing — All-Inclusive
Medication · Injection Supplies · Shipping · Clinical Oversight. One monthly price. No hidden fees.
Semaglutide
| Strength | Vial | Monthly |
|---|---|---|
| 2.5 mg | 0.5 mL | $169 |
| 5 mg | 1 mL | $205 |
| 10 mg | 2 mL | $237 |
Tirzepatide (First-Line Recommendation)
| Strength | Vial | Monthly |
|---|---|---|
| 10 mg | 1 mL | $201 |
| 20 mg | 2 mL | $237 |
| 30 mg | 3 mL | $297 |
| 40 mg | 4 mL | $345 |
| 60 mg | 6 mL | $465 |
Dosage determined by your provider based on health history and goals. Tirzepatide is our first-line recommendation.
The Tactical Advantage: GLP-1 Therapy
Integrating clinical metabolic intervention into the military operational readiness cycle.
Operational Performance
Improved fitness test scores and physical qualification standards for specialized and combat units.
Musculoskeletal Integrity
Reduced load on joints and connective tissue — lowering the risk of training and duty-related injuries.
Recovery Capacity
Faster physical recovery after strenuous training cycles and improved stamina during high-stress operations.
Circadian Resilience
Better sleep quality and stabilized energy levels — counteracting the metabolic effects of deployment and rotating assignments.
Metabolic Protection
Lower long-term risk of diabetes and cardiovascular disease — prevalent conditions in the veteran population.
Career Sustainability
Greater career longevity and reduced likelihood of weight-related medical retirement or service-connected disability claims.